Old Web
English
Sign In
Acemap
>
authorDetail
>
Jolanta Airey
Jolanta Airey
Quadrivalent Inactivated Influenza Vaccine
Immunogenicity
Influenza vaccine
Medicine
Hemagglutination assay
5
Papers
31
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
CSL112 (APOLIPOPROTEIN A-I [HUMAN]) SIMILARLY ENHANCES CHOLESTEROL EFFLUX CAPACITY IN JAPANESE AND CAUCASIAN SUBJECTS: FINDINGS FROM A PHASE 1 STUDY
2021
Journal of the American College of Cardiology
Michael A. Tortorici
Regina Clementi
John Feaster
Bo Zheng
Danielle Duffy
Penelope Dalitz
Jolanta Airey
John P. Roberts
Show All
Source
Cite
Save
Citations (0)
Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6–59 months of age: A phase 3, randomized, noninferiority study
2019
Vaccine
Victoria A. Statler
Frank R. Albano
Jolanta Airey
Daphne C. Sawlwin
Alison L Jones
Vince Matassa
Esther Heijnen
Jonathan Edelman
Gary S. Marshall
Show All
Source
Cite
Save
Citations (7)
Immunogenicity and safety of a quadrivalent inactivated influenza virus vaccine compared with a comparator quadrivalent inactivated influenza vaccine in a pediatric population: A phase 3, randomized noninferiority study
2017
Vaccine
Jolanta Airey
Frank R. Albano
Daphne C. Sawlwin
Alison L Jones
Neil Formica
Vince Matassa
Jane Leong
Show All
Source
Cite
Save
Citations (5)
Randomized Study To Compare Immunogenicity And Safety Of Seqirus* Quadrivalent Inactivated Influenza Vaccine With A US-Registered Influenza Vaccine In Paediatric Subjects Aged 5 To 17 Years
2016
Open Forum Infectious Diseases
Jane Leong
Daphne C. Sawlwin
Alison Graves-Jones
Neil Formica
Jolanta Airey
Frank R. Albano
Show All
Source
Cite
Save
Citations (0)
1